MSB 7.69% $1.19 mesoblast limited

Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-75

  1. 8,392 Posts.
    lightbulb Created with Sketch. 257
    How many do you reckon are in this category in OZ?

    "The Phase 3 trial is enrolling ventilator-dependent patients in intensive care units with moderate to severe COVID-19 ARDS randomized (1:1) to receive either two intravenous infusions of remestemcel-L three to five days apart or placebo on top of maximal care. The primary endpoint is all-cause mortality within 30 days of randomization, with the key secondary endpoint being the number of days off mechanical ventilator support."

    whilst any number on ventilators due to covid is to much, I believe not many are in this situation fortunately in OZ
    ...certainly not material numbers that would make a significant addition to the 300 sought imo
    Last edited by sunny coast: 02/09/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.